← All trials
NCT06165432
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 19, 2021
- Primary completion
- Sep 20, 2021
- Completion date
- Jan 5, 2022
- First posted
- Dec 11, 2023
- Last posted
- Dec 11, 2023
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- B.P. Koirala Institute of Health SciencesLead sponsor
- B.P. Koirala Institute of Health SciencesReponsible party - principal investigator
- B.P. Koirala Institute of Health SciencesSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.